Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Knight

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Clinical Transplantation|July 26, 2024
Lack of Association Between Donor-Derived Cell-Free DNA and Cardiac Allograft VasculopathyRami Alharethi, Stacey Knight, Helen I Luikart, et al.
Journal of Clinical Medicine|May 11, 2024
Coronary Calcium Is Elevated in Patients with Myocardial Infarction without Standard Modifiable Risk FactorsJeffrey L Anderson, Stacey Knight, Li Dong, et al.
Journal of the American Heart Association|November 20, 2023
Validation of an Integrated Genetic-Epigenetic Test for the Assessment of Coronary Heart DiseaseRobert Philibert, Timur K Dogan, Stacey Knight, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 8, 2007
Lack of agreement in pediatric emergency department discharge diagnoses from clinical and administrative data sourcesMarc H Gorelick, Stacey Knight, Evaline A Alessandrini, et al.
Journal of Clinical Medicine|May 13, 2023
Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare ExperienceJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
JAMA Network Open|April 5, 2021
Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US PopulationJeffrey L Anderson, Heidi T May, Stacey Knight, et al.
BMC Proceedings|December 19, 2009
Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart StudyStephen R Piccolo, Ryan P Abo, Kristina Allen-Brady, et al.
Journal of Clinical Medicine|January 8, 2023
Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare ExperienceJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Thrombosis and Haemostasis|February 1, 2013
Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genesJohn F Carlquist, Stacey Knight, Benjamin D Horne, et al.
Nutrients|July 13, 2024
Periodic Fasting and Acute Cardiac Events in Patients Evaluated for COVID-19: An Observational Prospective Cohort StudyBenjamin D Horne, Jeffrey L Anderson, Francois Haddad, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Clinical Transplantation|July 26, 2024
Lack of Association Between Donor-Derived Cell-Free DNA and Cardiac Allograft VasculopathyRami Alharethi, Stacey Knight, Helen I Luikart, et al.
Journal of Clinical Medicine|May 11, 2024
Coronary Calcium Is Elevated in Patients with Myocardial Infarction without Standard Modifiable Risk FactorsJeffrey L Anderson, Stacey Knight, Li Dong, et al.
Journal of the American Heart Association|November 20, 2023
Validation of an Integrated Genetic-Epigenetic Test for the Assessment of Coronary Heart DiseaseRobert Philibert, Timur K Dogan, Stacey Knight, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 8, 2007
Lack of agreement in pediatric emergency department discharge diagnoses from clinical and administrative data sourcesMarc H Gorelick, Stacey Knight, Evaline A Alessandrini, et al.
Journal of Clinical Medicine|May 13, 2023
Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare ExperienceJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
JAMA Network Open|April 5, 2021
Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US PopulationJeffrey L Anderson, Heidi T May, Stacey Knight, et al.
BMC Proceedings|December 19, 2009
Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart StudyStephen R Piccolo, Ryan P Abo, Kristina Allen-Brady, et al.
Journal of Clinical Medicine|January 8, 2023
Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare ExperienceJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Thrombosis and Haemostasis|February 1, 2013
Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genesJohn F Carlquist, Stacey Knight, Benjamin D Horne, et al.
Nutrients|July 13, 2024
Periodic Fasting and Acute Cardiac Events in Patients Evaluated for COVID-19: An Observational Prospective Cohort StudyBenjamin D Horne, Jeffrey L Anderson, Francois Haddad, et al.
Pageof 12